Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR2 | P25025 | 5/20 | 0.46 |
| ▸ | CXCR1 | P25024 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | LIG1 | P18858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6818505 | 0.86 | CXCR2 (0.44) | CXCR2CXCR1ALDH1A1MAPTLIG1 | |
| SCHEMBL6818508 | 0.86 | CXCR2 (0.44) | CXCR2CXCR1ALDH1A1MAPTLIG1 | |
| SCHEMBL7743008 | 0.83 | CXCR2 (0.43) | CXCR2CXCR1ALDH1A1MAPTPKM | |
| SCHEMBL7743014 | 0.83 | CXCR2 (0.43) | CXCR2CXCR1ALDH1A1MAPTPKM | |
| SCHEMBL6818590 | 0.78 | CXCR2 (0.44) | CXCR2CXCR1ALDH1A1LIG1POLB | |
| SCHEMBL6818514 | 0.78 | CXCR2 (0.44) | CXCR2CXCR1ALDH1A1LIG1 | |
| SCHEMBL5499098 | 0.76 | CXCR2 (0.76) | CXCR2CXCR1ALDH1A1MAPTPKM | |
| SCHEMBL5500791 | 0.76 | CXCR2 (0.46) | CXCR2CXCR1ALDH1A1MAPTPKM | |
| SCHEMBL27478409 | 0.72 | KDM4E (0.32) | ALDH1A1PKMLIG1 | |
| SCHEMBL506595 | 0.71 | ALDH1A1 (0.42) | ALDH1A1PKMLIG1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1191934-A4 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-02-04 | — | — | EP | disclosed |
| EP-0929302-A4 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2002-10-31 | — | — | EP | disclosed |
| EP-1191934-A1 | IL-8 RECEPTOR ANTAGONISTS | SmithKline Beecham Corporation (US) | 2002-04-03 | — | — | EP | disclosed |
| US-6204294-B1 | GUANIDINE CONTAINING COMPOUNDS | SMITHKLINE BEECHAM CORPORATION | 2001-03-20 | — | — | US | disclosed |
| WO-2000076516-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-12-21 | — | — | WO | disclosed |
| EP-0929302-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998006397-A1 | IL-8 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-19 | — | — | WO | disclosed |